Join four renowned experts in Women’s Health for the first of two sessions on The Pink Elephant - Breast Cancer Survivors & MHT. The first session will discuss this controversial topic and review the data regarding MHT in Breast Cancer Survivors.
Dr. Amy Comander (Mass General) is a breast oncologist at the Mass General Cancer Center, where she directs Breast Oncology, Cancer Survivorship, and the Lifestyle Medicine Program. As an Instructor at Harvard Medical School, she educates medical students and fellows while focusing on lifestyle medicine and cancer survivorship to improve patient outcomes.
An accomplished marathoner, Dr. Comander has completed 11 consecutive Boston Marathons to raise cancer awareness. She co-created “PAVING the Path to Wellness,” a 12-week survivorship program, and co-authored related workbooks. Through her nonprofit, Paving Wellness, she continues to support breast cancer survivors.
Dr. Comander serves on the American College of Lifestyle Medicine and the Ellie Fund boards and advises SurvivingBreastCancer.org.
Dr. Corinne Menn (Alloy) is a board-certified OBGYN and Menopause Society Certified Practitioner. She is also an over 23 year survivor of breast cancer and premature menopause, a BRCA carrier, and uses her experience to help women navigate their own health challenges. She has dedicated her medical practice to menopause management, the unique healthcare needs of female cancer survivors, and those at high risk for breast cancer. Now practicing exclusively through telehealth, Dr. Menn provides women’s health consultations and patient education. She is also a Medical Advisor and prescribing doctor on Alloy, a menopause telehealth platform.
Dr. Maryam Lustberg (Yale) is Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center and Chief of Breast Medical Oncology at Yale Cancer Center. A Professor of Medicine, she is recognized as one of Forbes’ top breast oncologists and named to Castle Connolly’s “Regional Top Doctors” and “Exceptional Women in Medicine.”
Dr. Lustberg’s research focuses on improving outcomes for breast cancer patients by addressing treatment side effects and developing blood-based biomarkers to detect recurrence and toxicity. An NCI-funded investigator, she collaborates globally and leads multidisciplinary teams. Her mentorship has earned awards like the Best Teacher Award from Hematology Oncology Fellows.
Nationally, Dr. Lustberg serves on ASCO committees, the Neuropathy Expert Guideline Panel, and as President-Elect of MASCC. She is also an Associate Editor for the Journal of Cancer Survivorship and an advocate for patient engagement in clinical trials. With over 140 publications, she is a leader in the field. She completed her MD and MPH at the University of Maryland and The Ohio State University.
Dr. Mary Jane Minkin (Yale) is a practicing gynecologist with a special focus on menopause and a North American Menopause Society Certified Menopause Clinician. She co-directs the Sexuality, Intimacy, and Menopause program for cancer survivors at Smilow Cancer Hospital and has taught at Yale School of Medicine for over 41 years as a Clinical Professor of Obstetrics, Gynecology, and Reproductive Sciences.
Recognized as a “Top Doc” by Connecticut Magazine, Dr. Minkin is committed to providing accessible menopause education. Her website, MadameOvary.com, features videos, podcasts, and articles offering valuable information about menopause.